Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0338420180330040823
The Korean Journal of Internal Medicine
2018 Volume.33 No. 4 p.823 ~ p.828
The relationship between anti-C-reactive protein and disease activity in patients with systemic lupus erythematosus
Son Chang-Nam

Lee Tae-Han
Bang Ji-Hye
Jeong Hye-Jin
Chae Jin-Nyeong
Lee Won-Mok
Kim Ji-Min
Kim Sang-Hyon
Abstract
Background/Aims: Anti-C-reactive protein (CRP) antibody has been introduced as a potential biologic marker in Systemic lupus erythematosus (SLE). The aim of study is to evaluate the level of anti-CRP antibody in patients with SLE.

Methods: This study investigated the relationship between levels of anti-CRP antibodies and disease activity markers, such as complement, anti-double-stranded DNA antibody, and SLE disease activity index in 34 patients with SLE.

Results: The serum anti-CRP antibody levels of the patients with SLE were significantly higher than those of the healthy controls (11.3 ¡¾ 5.6 ¥ìg/mL vs. 9.1 ¡¾ 2.8 ¥ìg/mL). The percentages of the positive anti-CRP antibody were 52.9% in SLE and 27.8% in controls. Disease duration of SLE showed significant correlation with the anti-CRP antibody (r = 0.234, p = 0.026). However no significant relationship was observed between the levels of anti-CRP antibodies and disease activity markers.

Conclusions: These data show that the anti-CRP antibody levels of the patients with SLE were significantly higher than those of healthy controls. We observed that the presence of the anti-CRP anti-CRP antibody was not associated with disease activity of SLE.
KEYWORD
Systemic lupus erythematosus, Anti-C-reactive protein antibody
FullTexts / Linksout information
 
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø